Biotech | April 16, 2026
Clean Cells, Naobios step up Asia expansion at BIO KOREA 2026 in Seoul
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
Longest survival follow-up ever reported for immunotherapy treatment in this setting
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
N-nitroso dimethylamine (NDMA) is a probable human carcinogen and tts effects on humans rely on observational studies.
Cytel has now established entities in Australia, Shanghai, Beijing, and Singapore, and plans to expand into Seoul and Tokyo in the coming years.
Global event to kick off as the post-covid era begins in earnest, with theme "beyond the pandemic, into a next wave"
Arum's research focuses on the discovery of new chemical entities that will act as effective therapies for drug-resistant cancers
Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub
These results will be presented on 21 January at the 2022 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
Subscribe To Our Newsletter & Stay Updated
